Freedom from structural valve deterioration among patients aged ≤60 years undergoing Freestyle® stentless aortic valve replacement

Journal of Heart Valve Disease

Volumn 16, Issue 6, 2007, Pages 649-656

  Bach, David S ^a   Metras, Jacques ^b   Doty, John R ^c   Yun, Kwok L ^d   Dumesnil, Jean G ^b   Kon, Neal D ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c LDS HOSPITAL   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA INJURY; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEART VALVE BIOPROSTHESIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TREATMENT DURATION;

AGED; AORTIC VALVE; BIOPROSTHESIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROSTHESIS DESIGN; REOPERATION;

EID: 36949018209     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 2006;48:e1-e148
2. Poirier NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 1998;66:S57-S61
3. Banbury MK, Cosgrove DM, III, White JA, Blackstone EH, Frater RWM, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753-757
4. Jamieson WRE, Burr LH, Munro AI, Miyagishima RT. Carpentier-Edwards standard porcine bioprosthesis. A 21-year experience. Ann Thorac Surg 1998;66:S40-S43
5. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-278
6. Rizzoli G, Bottio T, Thiene G, Toscano G, Casarotto D. Long-term durability of the Hancock II porcine bioprosthesis. J Thorac Cardiovasc Surg 2003;126:66-74
7. Milano AD, Blanzola C, Mecozzi G, et al. Hemodynamic performance of stented and stent-less aortic bioprosthesis. Ann Thorac Surg 2001;72:33-38
8. Bakhtiary F, Schiemann M, Dzemali O, et al. Stentless bioprosthesis improve postoperative coronary flow more than stented prostheses after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 2006;131:883-888
9. Bakhtiary F, Schiemann M, Dzemali O, et al. Impact of patient-prosthesis mismatch and aortic valve design on coronary flow reserve after aortic valve replacement. J Am Coll Cardiol 2007;49:790-796
10. David TE, Puschmann R, Ivanov J, et al. Aortic valve replacement with stentless and stented porcine valves: A case-match study. J Thorac Cardiovasc Surg 1998;116:236-241.
11. Del Rizzo DF, Abdoh A, Cartier P, Doty D, Westaby S. The effect of prosthetic valve type on survival after aortic valve surgery. Semin Thorac Cardiovasc Surg 1999;11(Suppl.1):1-8
12. Westaby S, Horton M, Jin XY, et al. Survival advantage of stentless aortic bioprosthesis. Ann Thorac Surg 2000;70:785-791
13. Melina G, Rubens MB, Amrani M, Khaghani A, Yacoub MH. Electron beam tomography for cusp calcification in homograft versus Freestyle xenografts. Ann Thorac Surg 2001;71(Suppl.):S368-S370
14. Bach DS, Kon ND, Dumesnil JG, Sintek CF, Doty DB. Ten-year outcome after aortic valve replacement with the Freestyle stentless bioprosthesis. Ann Thorac Surg 2005;80:480-487
15. Doty DB, Cafferty A, Cartier P, et al. Aortic valve replacement with Medtronic Freestyle bioprosthesis: Five year results. Semin Thorac Cardiovasc Surg 1999;11(4 Suppl.1):35-41
16. Bach DS, Cartier PA, Kon N, Johnson KG, Deeb GM, Doty DB. Impact of implant technique following Freestyle® stentless aortic valve replacement. Ann Thorac Surg 2002;74:1107-1114
17. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1988;46:257-259
18. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268
19. Desai ND, Merin O, Cohen GN, et al. Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve. Ann Thorac Surg 2004;78:2076-2083
20. Martin JW, Deeb GM, Bach DS. The sinotubular junction does not progressively dilate four years after modified subcoronary Freestyle stentless tissue aortic valve replacement. J Heart Valve Dis 2003;12:726-733
21. David TE, Ivanov J, Eriksson MJ, Bos J, Feindel CM, Rakowski H. Dilation of the sinotubular junction causes aortic insufficiency after aortic valve replacement with the Toronto SPV bioprosthesis. J Thorac Cardiovasc Surg 2001;122:929-934